{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-26T04:46:50.313388+00:00","published_at":"2026-10-26T04:46:50.313388+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:security_listing:22","stance":"supports"}],"claim_ids":["alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:legal_name:1","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:entity_status:3","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:published_fact:4","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:security_listing:22"]},{"evidence_id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","aliases":[],"source_type":"sec_def_14a","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","title":"SEC DEF 14A 0001193125-26-186944","identifier":null,"locator":null,"source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:5","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:6","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:7","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:10","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:11","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:13","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:14","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:16","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:18","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:19","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:21","stance":"supports"}],"claim_ids":["alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:5","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:6","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:7","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:10","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:11","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:13","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:14","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:16","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:18","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:19","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:21"]},{"evidence_id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","title":"DEF 14A d133143ddef14a.htm","identifier":null,"locator":null,"source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:8","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:9","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:12","stance":"supports"},{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:15","stance":"supports"}],"claim_ids":["alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:8","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:9","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:12","alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:15"]},{"evidence_id":"alpha:projection-evidence:document:8b2303f36f6ec815a7666e8fbf6d2fa62a3ea6eec91c90ebbafc8c675b1d6834","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","title":"BBOT DEF 14A executive officers","identifier":null,"locator":null,"source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:14.882162+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:17","stance":"supports"}],"claim_ids":["alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:17"]},{"evidence_id":"alpha:projection-evidence:document:623cc5b73fa680065bca4d0583ebe97802a3965a3751f6a2d519839572b90204","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","title":"BBOT DEF 14A executive officers","identifier":null,"locator":null,"source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:15.461031+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:20","stance":"supports"}],"claim_ids":["alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:20"]}]},"claims":[{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:legal_name:1","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BridgeBio Oncology Therapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"BridgeBio Oncology Therapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:entity_status:3","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:published_fact:4","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:5","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jake-bauer-bbot","object_label":"Jake Bauer","object_source_name_forms":[],"value":"Jake Bauer: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jake-bauer-bbot","name":"Jake Bauer"},"title":"Chairman of the Board","role_category":"director","committee":null,"is_board_chair":true,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:6","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bihua-chen-m-b-a","object_label":"Bihua Chen, M.B.A.","object_source_name_forms":[],"value":"Bihua Chen, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bihua-chen-m-b-a","name":"Bihua Chen, M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:7","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:frank-p-mccormick-ph-d-f-r-s-d-sc-bridgebio-oncology-therapeutics-inc","object_label":"Frank P. McCormick, Ph.D., F.R.S., D.Sc.","object_source_name_forms":[],"value":"Frank P. McCormick, Ph.D., F.R.S., D.Sc.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:frank-p-mccormick-ph-d-f-r-s-d-sc-bridgebio-oncology-therapeutics-inc","name":"Frank P. McCormick, Ph.D., F.R.S., D.Sc."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:8","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michelle-doig-bbot","object_label":"Michelle Doig","object_source_name_forms":[],"value":"Michelle Doig: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michelle-doig-bbot","name":"Michelle Doig"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:9","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neil-kumar-bbot","object_label":"Neil Kumar","object_source_name_forms":[],"value":"Neil Kumar: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:neil-kumar-bbot","name":"Neil Kumar"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:10","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neil-kumar-ph-d","object_label":"Neil Kumar, Ph.D.","object_source_name_forms":[],"value":"Neil Kumar, Ph.D.: Executive Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:neil-kumar-ph-d","name":"Neil Kumar, Ph.D."},"title":"Executive Chairman of the Board","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:11","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:pedro-j-beltran-ph-d","object_label":"Pedro J. Beltran, Ph.D.","object_source_name_forms":[],"value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:pedro-j-beltran-ph-d","name":"Pedro J. Beltran, Ph.D."},"title":"Chief Executive Officer and Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:12","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-lebowitz-bbot","object_label":"Peter Lebowitz","object_source_name_forms":[],"value":"Peter Lebowitz: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-lebowitz-bbot","name":"Peter Lebowitz"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:13","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-lebowitz-m-d-ph-d-bridgebio-oncology-therapeutics-inc","object_label":"Peter Lebowitz, M.D., Ph.D.","object_source_name_forms":[],"value":"Peter Lebowitz, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-lebowitz-m-d-ph-d-bridgebio-oncology-therapeutics-inc","name":"Peter Lebowitz, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:14","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:praveen-tipirneni-m-d-m-b-a-bridgebio-oncology-therapeutics-inc","object_label":"Praveen Tipirneni, M.D., M.B.A.","object_source_name_forms":[],"value":"Praveen Tipirneni, M.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:praveen-tipirneni-m-d-m-b-a-bridgebio-oncology-therapeutics-inc","name":"Praveen Tipirneni, M.D., M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:15","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-kelleher-bbot","object_label":"Raymond Kelleher","object_source_name_forms":[],"value":"Raymond Kelleher: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-kelleher-bbot","name":"Raymond Kelleher"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:16","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-kelleher-m-d-ph-d-bridgebio-oncology-therapeutics-inc","object_label":"Raymond Kelleher, M.D., Ph.D.","object_source_name_forms":[],"value":"Raymond Kelleher, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-kelleher-m-d-ph-d-bridgebio-oncology-therapeutics-inc","name":"Raymond Kelleher, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:17","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eli-wallace-ph-d","object_label":"Eli Wallace, Ph.D.","object_source_name_forms":[],"value":"Eli Wallace, Ph.D.: Chief Executive Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eli-wallace-ph-d","name":"Eli Wallace, Ph.D."},"title":"Chief Executive Officer and President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:8b2303f36f6ec815a7666e8fbf6d2fa62a3ea6eec91c90ebbafc8c675b1d6834","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:14.882162+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:18","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:idan-elmelech-bridgebio-oncology-therapeutics-inc","object_label":"Idan Elmelech","object_source_name_forms":[],"value":"Idan Elmelech: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:idan-elmelech-bridgebio-oncology-therapeutics-inc","name":"Idan Elmelech"},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:19","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:pedro-j-beltran-ph-d","object_label":"Pedro J. Beltran, Ph.D.","object_source_name_forms":[],"value":"Pedro J. Beltran, Ph.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:pedro-j-beltran-ph-d","name":"Pedro J. Beltran, Ph.D."},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:20","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:uneek-mehra","object_label":"Uneek Mehra","object_source_name_forms":[],"value":"Uneek Mehra: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:uneek-mehra","name":"Uneek Mehra"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:623cc5b73fa680065bca4d0583ebe97802a3965a3751f6a2d519839572b90204","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:15.461031+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:leadership_role:21","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:yong-ben-m-d-m-b-a","object_label":"Yong Ben, M.D., M.B.A.","object_source_name_forms":[],"value":"Yong Ben, M.D., M.B.A.: Chief Medical and Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:yong-ben-m-d-m-b-a","name":"Yong Ben, M.D., M.B.A."},"title":"Chief Medical and Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f:security_listing:22","subject_id":"alpha:company:b61e4e0a-2ea1-468b-a1bb-2065eda1737f","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"BBOT (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"BBOT","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-26T04:46:50.313388+00:00","sources":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:87582eedadb599856a8197a9c2de0a573ea2932544dd0c541e1efedcdfa8c23c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc","source_date":null,"retrieved_at":"2026-10-26T04:46:50.313388+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:59acdd75dbb4a409feb947c32718a509592d6cb8b175292f5e9c7e1ce1811b3a","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001193125-26-186944","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T01:32:42.223762+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4fb2caaa7b87f699564646847e39507307d10c4510786336f3cacd28be8b7dc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A d133143ddef14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:08:37.701537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8b2303f36f6ec815a7666e8fbf6d2fa62a3ea6eec91c90ebbafc8c675b1d6834","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:14.882162+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:623cc5b73fa680065bca4d0583ebe97802a3965a3751f6a2d519839572b90204","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BBOT DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526186944/d133143ddef14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-15T23:21:15.461031+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.824,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.353},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":6,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-26T04:46:50.313388+00:00","observed_at":"2026-10-26T04:46:50.313388+00:00","reviewed_at":"2026-10-26T04:46:50.313388+00:00","verified_at":"2026-10-26T04:46:50.313388+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/bridgebio-oncology-therapeutics-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/bridgebio-oncology-therapeutics-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}